Search

Your search keyword '"McKiernan G"' showing total 8 results
Start Over Author "McKiernan G" Search Limiters Full Text
8 results on '"McKiernan G"'

1. First in Human Study of In-vivo Imaging of Ex-Vivo Labelled CAR T Cells with Dual PET-MR

Author

Singla, R., primary, Wall, D., additional, Anderson, S., additional, Zia, N., additional, Korte, J., additional, Kravets, L., additional, McKiernan, G., additional, Butler, J., additional, Gammilonghi, A., additional, Arora, J., additional, Wright, M., additional, Solomon, B., additional, Hicks, R.J., additional, Cain, T., additional, Darcy, P., additional, Cullinane, C., additional, Neeson, P., additional, Ramanathan, R., additional, Shukla, R., additional, Bansal, V., additional, and Harrison, S., additional

Published
2020
Full Text
View/download PDF

2. Time-resolved compression of a capsule with a cone to high density for fast-ignition laser fusion

Author

Theobald, W., primary, Solodov, A. A., additional, Stoeckl, C., additional, Anderson, K. S., additional, Beg, F. N., additional, Epstein, R., additional, Fiksel, G., additional, Giraldez, E. M., additional, Glebov, V. Yu., additional, Habara, H., additional, Ivancic, S., additional, Jarrott, L. C., additional, Marshall, F. J., additional, McKiernan, G., additional, McLean, H. S., additional, Mileham, C., additional, Nilson, P. M., additional, Patel, P. K., additional, Pérez, F., additional, Sangster, T. C., additional, Santos, J. J., additional, Sawada, H., additional, Shvydky, A., additional, Stephens, R. B., additional, and Wei, M. S., additional

Published
2014
Full Text
View/download PDF

3. Plasma exchange treatment of peripheral neuropathy associated with plasma cell dyscrasia.

Author

Sherman, W H, Olarte, M R, McKiernan, G, Sweeney, K, Latov, N, and Hays, A P

Abstract

Plasma exchange was used to treat 10 patients with polyneuropathy and a monoclonal antibody (plasma cell dyscrasia). Six patients had improvement of the neuropathy, while three patients had stabilisation of the neuropathy during plasma exchange. The patients who improved maintained a 64% or greater decrease in the monoclonal antibody between exchanges. Patients with axonal polyneuropathy as well as patients with demyelinating polyneuropathy recovered some neurologic function. With cessation of plasma exchanges, the monoclonal antibody titre approached pre-treatment levels and the neuropathy progressed. Plasma exchange was effective in rapidly lowering the level of monoclonal antibody and allowing for some recovery of neurologic function. [ABSTRACT FROM AUTHOR]

Published
1984

7. Photopheresis therapy of cutaneous T-cell lymphoma: the Yale-New Haven Hospital experience

Author

Heald, P. W., Perez, M. I., Christensen, I., Dobbs, N., McKiernan, G., and Edelson, R.

Subjects
Adult, Extracorporeal Circulation, Skin Neoplasms, Lymphoma, T-Lymphocytes, Humans, Methoxsalen, Middle Aged, PUVA Therapy, Dermatitis, Exfoliative, Research Article, Aged, Skin
Abstract

Over the past two years, the photopheresis treatment program at Yale-New Haven Hospital has treated 32 patients with cutaneous T-cell lymphoma. There were 19 erythrodermic patients who had photopheresis as their first systemic therapy. Five of these cleared 75 percent of their skin and the majority of erythrodermics achieved an improved quality of life. Those with best responses were treated earlier in the course of their disease and had more normal proportions of CD4 and CD8 subsets when compared to patients with poor responses. In addition, patients with tumor stage disease and those patients in relapse after intensive radio- and chemotherapy were treated with photopheresis. These results demonstrate that photopheresis has a role in the management of cutaneous T-cell lymphoma. Images FIG. 3

Published
1989

Catalog

Books, media, physical & digital resources
See catalog results